Abstract
The synthesis of a series of 2,4-disubstituted morpholines is described and their affinities at human dopamine receptors reported. The orally bioavailable 7-azaindole compound 11 has nanomolar affinity at the hD4 receptor with > 1000-fold selectivity over the hD2 receptor.
MeSH terms
-
Administration, Oral
-
Animals
-
Binding, Competitive
-
Biological Availability
-
Cell Line
-
Humans
-
Injections, Intravenous
-
Models, Molecular
-
Morpholines / chemical synthesis
-
Morpholines / metabolism*
-
Morpholines / pharmacokinetics
-
Pyridines / chemical synthesis
-
Pyridines / metabolism*
-
Pyridines / pharmacokinetics
-
Radioligand Assay
-
Rats
-
Receptors, Dopamine D2 / metabolism*
-
Receptors, Dopamine D4
-
Spiperone / metabolism
-
Structure-Activity Relationship
-
Tritium
Substances
-
3-((2-((4-chlorophenoxy)methyl)morpholin-4-yl)methyl)pyrrolo(2,3-b)pyridine
-
DRD4 protein, human
-
Drd4 protein, rat
-
Morpholines
-
Pyridines
-
Receptors, Dopamine D2
-
Tritium
-
Receptors, Dopamine D4
-
Spiperone